Tuesday, September 22, 2020

US FDA News: FDA Clarifies Types of Evidence Relevant to Determining the “Intended Use” of FDA-Regulated Products

FDA proposal to clarify regulations about the types of evidence relevant to determining how a manufacturer intends for its product to be used by health care providers and patients, an area known as intended use.
Read more: FDA Clarifies Types of Evidence Relevant to Determining the “Intended Use” of FDA-Regulated Products